<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04239118</url>
  </required_header>
  <id_info>
    <org_study_id>Cherednikov</org_study_id>
    <nct_id>NCT04239118</nct_id>
  </id_info>
  <brief_title>New Technologies for Endoscopic Treatment of Bleeding Gastroduodenal Ulcers</brief_title>
  <official_title>New Technologies for Endoscopic Treatment of Bleeding Gastroduodenal Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Voronezh N.N. Burdenko State Medical Academy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Voronezh N.N. Burdenko State Medical Academy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study was to improve treatment results of patients with bleeding
      gastroduodenal ulcers by endoscopic applications of autoplasma, enriched with platelets and
      granular sorbent aseptisorb-A.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The clinical study was conducted on the basis of the Voronezh city specialized Center for the
      treatment of patients with gastrointestinal bleeding. The study included 112 patients with
      ulcerative gastroduodenal bleeding. All patients were divided into two groups by random
      sampling: the main group (n=57 people) and the comparison group (n=55 people). In the
      treatment of patients of the main group (57 people), an individual approach was used with the
      use of granular sorbent aseptisorb-A and autoplasm enriched with platelets, in the complex
      endoscopic treatment of bleeding-complicated gastroduodenal ulcers (Patent Russian Federation
      (RF) â„– 2632771). In the comparison group (55 people), traditional methods of endoscopic
      hemostasis were used.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 10, 2018</start_date>
  <completion_date type="Actual">December 20, 2019</completion_date>
  <primary_completion_date type="Actual">June 16, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the timing of final hemostasis</measure>
    <time_frame>a week</time_frame>
    <description>the timing of final hemostasis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the frequency of recurrent bleeding</measure>
    <time_frame>1 year</time_frame>
    <description>the frequency of recurrent bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mortality rates</measure>
    <time_frame>1 year</time_frame>
    <description>mortality rates</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>healing of ulcerative defects</measure>
    <time_frame>1 year</time_frame>
    <description>sizes of ulcerative defects</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">112</enrollment>
  <condition>Ulcer Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Applications of autoplasma, enriched with platelets and</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endoscopic applications of autoplasma, enriched with platelets and granular sorbent aseptisorb-A in bleeding gastroduodenal ulcers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional methods of endoscopic hemostasis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Traditional methods of endoscopic hemostasis were used without the use of platelet-enriched plasma and granular sorbents.</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Complex endoscopic treatment with the use of granular sorbent aseptisorb-A and autoplasm enriched with platelets</intervention_name>
    <description>Complex endoscopic bleeding ulcers treatment with the use of granular sorbent aseptisorb-A and autoplasm enriched with platelets</description>
    <arm_group_label>Applications of autoplasma, enriched with platelets and</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Traditional methods of endoscopic hemostasis</intervention_name>
    <description>Traditional methods of endoscopic hemostasis were used without the use of platelet-enriched plasma and granular sorbents</description>
    <arm_group_label>Traditional methods of endoscopic hemostasis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gastroduodenal ulcers with bleeding

        Exclusion Criteria:

          -  Bleedings of other etiology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>44 Years</minimum_age>
    <maximum_age>67 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Voronezh State Medical University</name>
      <address>
        <city>Voronezh</city>
        <zip>394019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 19, 2020</study_first_submitted>
  <study_first_submitted_qc>January 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2020</study_first_posted>
  <last_update_submitted>January 19, 2020</last_update_submitted>
  <last_update_submitted_qc>January 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ulcer</keyword>
  <keyword>bleeding</keyword>
  <keyword>treatment</keyword>
  <keyword>aseptisorb-A</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peptic Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

